156 related articles for article (PubMed ID: 17334353)
1. Phyllodes tumors of the breast segregate in two groups according to genetic criteria.
Laé M; Vincent-Salomon A; Savignoni A; Huon I; Fréneaux P; Sigal-Zafrani B; Aurias A; Sastre-Garau X; Couturier J
Mod Pathol; 2007 Apr; 20(4):435-44. PubMed ID: 17334353
[TBL] [Abstract][Full Text] [Related]
2. Whole-genome profiling helps to classify phyllodes tumours of the breast.
Laé M; La Rosa P; Mandel J; Reyal F; Hupé P; Terrier P; Couturier J
J Clin Pathol; 2016 Dec; 69(12):1081-1087. PubMed ID: 27207013
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal aberrations and genetic relations in benign, borderline and malignant phyllodes tumors of the breast: a comparative genomic hybridization study.
Lv S; Niu Y; Wei L; Liu Q; Wang X; Chen Y
Breast Cancer Res Treat; 2008 Dec; 112(3):411-8. PubMed ID: 18189161
[TBL] [Abstract][Full Text] [Related]
4. Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression.
Ang MK; Ooi AS; Thike AA; Tan P; Zhang Z; Dykema K; Furge K; Teh BT; Tan PH
Breast Cancer Res Treat; 2011 Sep; 129(2):319-29. PubMed ID: 20945089
[TBL] [Abstract][Full Text] [Related]
5. Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence.
Lu YJ; Birdsall S; Osin P; Gusterson B; Shipley J
Genes Chromosomes Cancer; 1997 Nov; 20(3):275-81. PubMed ID: 9365835
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence.
Jones AM; Mitter R; Springall R; Graham T; Winter E; Gillett C; Hanby AM; Tomlinson IP; Sawyer EJ;
J Pathol; 2008 Apr; 214(5):533-44. PubMed ID: 18288784
[TBL] [Abstract][Full Text] [Related]
7. Genomic profiling by array comparative genomic hybridization reveals novel DNA copy number changes in breast phyllodes tumours.
Kuijper A; Snijders AM; Berns EM; Kuenen-Boumeester V; van der Wall E; Albertson DG; van Diest PJ
Cell Oncol; 2009; 31(1):31-9. PubMed ID: 19096148
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.
Liu SY; Joseph NM; Ravindranathan A; Stohr BA; Greenland NY; Vohra P; Hosfield E; Yeh I; Talevich E; Onodera C; Van Ziffle JA; Grenert JP; Bastian BC; Chen YY; Krings G
Mod Pathol; 2016 Sep; 29(9):1012-27. PubMed ID: 27255162
[TBL] [Abstract][Full Text] [Related]
9. Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression.
Kersting C; Kuijper A; Schmidt H; Packeisen J; Liedtke C; Tidow N; Gustmann C; Hinrichs B; Wülfing P; Tio J; Boecker W; van Diest P; Brandt B; Buerger H
Lab Invest; 2006 Jan; 86(1):54-61. PubMed ID: 16258523
[TBL] [Abstract][Full Text] [Related]
10. Loss of SDHB and NF1 genes in a malignant phyllodes tumor of the breast as detected by oligo-array comparative genomic hybridization.
Lee J; Wang J; Torbenson M; Lu Y; Liu QZ; Li S
Cancer Genet Cytogenet; 2010 Jan; 196(2):179-83. PubMed ID: 20082856
[TBL] [Abstract][Full Text] [Related]
11. MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways.
Laé M; Gardrat S; Rondeau S; Richardot C; Caly M; Chemlali W; Vacher S; Couturier J; Mariani O; Terrier P; Bièche I
Oncotarget; 2016 Dec; 7(51):84428-84438. PubMed ID: 27806318
[TBL] [Abstract][Full Text] [Related]
12. Quantification of the morphologic features of fibroepithelial tumors of the breast.
McKenna AM; Pintilie M; Youngson B; Done SJ
Arch Pathol Lab Med; 2007 Oct; 131(10):1568-73. PubMed ID: 17922594
[TBL] [Abstract][Full Text] [Related]
13. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
14. Karyotypic changes in phyllodes tumors of the breast.
Dietrich CU; Pandis N; Bardi G; Teixeira MR; Soukhikh T; Petersson C; Andersen JA; Heim S
Cancer Genet Cytogenet; 1994 Dec; 78(2):200-6. PubMed ID: 7828153
[TBL] [Abstract][Full Text] [Related]
15. [The important morphological parameters used to differentiate benign/malignant phyllodes tumors of the breast].
Küçük Ü; Pala EE; Bayol Ü; Erdoğan IG
Turk Patoloji Derg; 2012; 28(3):245-50. PubMed ID: 23011827
[TBL] [Abstract][Full Text] [Related]
16. Trends in the Diagnosis of Phyllodes Tumors and Fibroadenomas Before and After Release of WHO Classification Standards.
Chang J; Denham L; Dong EK; Malek K; Lum SS
Ann Surg Oncol; 2018 Oct; 25(10):3088-3095. PubMed ID: 29987607
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of pleomorphic liposarcomatous differentiation in malignant phyllodes tumor of the breast: A case report.
Zhou P; Zhang Q; Zhu J; Li P
Pathol Res Pract; 2021 Aug; 224():153489. PubMed ID: 34091389
[TBL] [Abstract][Full Text] [Related]
18. Gain in 1q is a common abnormality in phyllodes tumours of the breast.
Jee KJ; Gong G; Ahn SH; Park JM; Knuutila S
Anal Cell Pathol; 2003; 25(2):89-93. PubMed ID: 12632018
[TBL] [Abstract][Full Text] [Related]
19. Molecular cytogenetics of primary breast cancer by CGH.
Tirkkonen M; Tanner M; Karhu R; Kallioniemi A; Isola J; Kallioniemi OP
Genes Chromosomes Cancer; 1998 Mar; 21(3):177-84. PubMed ID: 9523192
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components.
Sawyer EJ; Hanby AM; Ellis P; Lakhani SR; Ellis IO; Boyle S; Tomlinson IP
Am J Pathol; 2000 Mar; 156(3):1093-8. PubMed ID: 10702425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
